Insider Buying: Vitalhub (TSE:VHI) Director Buys 50,000 Shares of Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen acquired 50,000 shares of the firm’s stock in a transaction dated Thursday, March 26th. The shares were purchased at an average cost of C$6.99 per share, for a total transaction of C$349,500.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at approximately C$349,500. This represents a ∞ increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Tuesday, March 24th, Francis Nelson Shen bought 439,600 shares of Vitalhub stock. The shares were purchased at an average price of C$7.00 per share, with a total value of C$3,077,200.00.

Vitalhub Trading Down 0.7%

VHI traded down C$0.05 during trading hours on Friday, hitting C$6.93. The company’s stock had a trading volume of 208,775 shares, compared to its average volume of 359,939. The business’s 50-day moving average price is C$8.10 and its 200-day moving average price is C$9.35. Vitalhub Corp. has a 12 month low of C$6.67 and a 12 month high of C$14.64. The stock has a market cap of C$438.20 million, a price-to-earnings ratio of 69.30, a P/E/G ratio of 1.18 and a beta of 0.65.

Vitalhub (TSE:VHI) last released its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. The company had revenue of C$31.39 million for the quarter. On average, analysts forecast that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on VHI shares. Scotiabank lowered their price target on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. ATB Cormark Capital Markets decreased their price objective on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 10th. Raymond James Financial lowered their price objective on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, Royal Bank Of Canada dropped their target price on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a report on Monday, January 26th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to MarketBeat, Vitalhub has an average rating of “Buy” and an average price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.